Expert Review of Gastroenterology & Hepatology

Papers
(The median citation count of Expert Review of Gastroenterology & Hepatology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Small bowel transplant – novel indications and recent progress47
Multidetector computed tomography angiography in non-variceal upper gastrointestinal bleeding: when, why and how?38
Ripretinib for the treatment of adult patients with advanced gastrointestinal stromal tumors33
Managing pain in irritable bowel syndrome: current perspectives and best practice31
Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives30
Impact of yoga therapy in intestinal disorders27
Therapeutic drug monitoring in inflammatory bowel disease: recent developments26
Addressing current limitations of colonoscopy for colorectal cancer screening26
Targeting liver metabolism: a pathway to cure hepatitis B virus?26
Imaging in pediatric disorders of the gut-brain interactions: current best practice and future directions26
Irritable bowel syndrome – controversies in diagnosis and management25
Early alpha-fetoprotein response predicts prognosis of immune checkpoint inhibitor and targeted therapy for hepatocellular carcinoma: a systematic review with meta-analysis25
Lipid biomarkers in colorectal cancer, with particular emphasis on exosomes – current status and future inferences25
Recent advances in treating constipation in children24
Gender-related differences in celiac disease presentation and follow-up in adult patients23
Familial intestinal polyposis and device assisted enteroscopy: where do we stand?22
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease22
Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms22
The assessment of impaired liver function and prognosis in hepatocellular carcinoma21
A narrative review on the diagnosis and management of constipation in infants20
Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)20
Elucidating the role of extracellular vesicles in liver injury induced by HIV20
High-dosage human albumin infusion may be superior for hypervolemic hyponatremia in cirrhosis with ascites20
ERCP-related adverse events: incidence, mechanisms, risk factors, prevention, and management19
An insight into Clostridioides difficile-associated diarrhea in Saudi children: diagnosis and treatment18
Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities18
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized cont18
Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction18
Recent updates on treatment options for primary follicular lymphoma of the gastrointestinal tract18
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?17
Preoperative endoscopic ultrasound-guided biliary drainage for primary drainage in obstructive jaundice17
Investigating the correlation between COVID-19 and the progression of chronic liver disease17
Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice17
Managing bile acid diarrhea: aspects of contention16
The evolution of irritable bowel syndrome as a group of organic diseases: a narrative review16
To STRIDE or not to STRIDE: a critique of “treat to target” in ulcerative colitis15
Altered gut microbiota is associated with sleep disturbances in patients with minimal hepatic encephalopathy caused by hepatitis B-related liver cirrhosis15
Small bowel imaging in inflammatory bowel disease: updates for 202315
IBD in women of reproductive age: where do novel therapies fit in?15
Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis15
The impact of a multidisciplinary team evaluation on the diagnosis and management of acute and chronic pancreatitis in a tertiary referral center14
Evaluating the role of endoscopic ultrasound in pancreatitis14
Cost-effectiveness of tislelizumab plus chemotherapy vs chemotherapy as first-line treatment of PD-L1 positive advanced gastric or gastroesophageal junction adenocarcinoma from a Chinese perspective14
Psychological distress in inflammatory bowel disease14
Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States14
Updates on intestinal failure management14
An update on improving long-term outcomes for patients with chronic pancreatitis post-surgery13
Highlights of the drug-induced liver injury literature for 202113
Managing pediatric Crohn’s disease: recent insights13
Primary biliary cholangitis (PBC): evolving approaches and expert perspectives12
Techniques and outcomes review of the endoscopic management of gastrointestinal bleeding12
Carcinoid syndrome mimicking irritable bowel syndrome: don’t fall into the trap12
Artificial intelligence implementation in pancreaticobiliary endoscopy12
Noninvasive diagnosis of clinically significant portal hypertension: current evidence and future directions12
Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults11
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma11
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays11
Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review11
Gastroesophageal reflux disease in preterm infants: unmet needs11
Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis11
Diagnosing eosinophilic esophagitis in pediatric patients11
Managing complications of chronic pancreatitis: a guide for the gastroenterologist11
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art10
Management of disease-related abdominal abscesses in Crohn’s disease10
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges10
Reply to letter to the Editor: Vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis10
An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-α, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate rece10
Updates in interaction of gastroesophageal reflux disease and extragastroesophageal digestive diseases10
The efficacy and safety of glucocorticoid for perioperative patients with hepatectomy: a systematic review and meta-analysis9
Modulating the microbiome in chronic liver diseases – current evidence on the role of fecal microbiota transplantation9
Towards a better diagnosis of gastro esophageal reflux disease9
Highlighting novel targets in immunotherapy for liver cancer9
EUS-guided gastro-enteral anastomosis for the treatment of gastric outlet obstruction: is the end of the enteral stent?9
Development and validation of modified Liaoning score for predicting the prognosis of liver cirrhosis: a retrospective, international multicenter, observational study9
Post-endoscopic submucosal dissection electrocoagulation syndrome: a clinical overview9
Assessment of efficacy and prognostic factors by Gelfoam for DEB-TACE in unresectable large hepatocellular carcinoma with portal vein tumor thrombus: a multi-center retrospective study8
Induction and maintenance of healing in erosive esophagitis in the United States8
Endoscopic ultrasound-guided pancreatic duct drainage: a comprehensive state of the art review8
Histamine-producing bacteria and their role in gastrointestinal disorders8
Introducing the “Guideline Comparison” article type8
Clinical management of inflammatory bowel disease from preconception to postpartum8
PSC patient with jaundice – should we ERCP?8
Safety and use of IBD therapies during pregnancy and lactation8
Radiation safety and dose management in fluoroscopy-guided gastrointestinal procedures: current evidence and future perspectives8
Medical management of acute severe ulcerative colitis in the hospitalized patient8
Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease8
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease8
Autoimmune gastritis: an organ-specific disease or a model of systemic autoimmunity? Parallels, divergences, and emerging insights8
Characterizing Crohn’s disease phenotypes through pan-enteric capsule endoscopy8
Acute severe ulcerative colitis: defining the precise moment for colectomy8
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma8
Clinical role of anti-PD-1 immunotherapies in esophageal cancer8
Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis8
Nutritional aspects of inflammatory bowel disease8
Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis8
Endoscopic follow-up in patients with first-degree relatives for gastric cancer: a real-world observational study8
Systematic mapping of worldwide research on intra-pancreatic fat deposition8
The TL1A inhibitors in IBD: what’s in the pot?8
Exploring immunological perturbations between hepatocellular carcinoma risk, inflammation and obesity8
The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors7
2023 update on the clinical management of gastroparesis7
Prioritization in inflammatory bowel disease therapy7
To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease7
The eternal dichotomy between early biologic therapy and early surgery in Crohn’s disease: which should truly take precedence?7
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease7
Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure7
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms7
Noninvasive electrical neuromodulation for gastrointestinal motility disorders7
Proton beam therapy in the management of hepatocellular carcinoma7
Primary biliary cholangitis: primary autoimmune disease or primary secretory defect7
How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities7
Analysis of the impact on efficacy of lubiprostone dose reduction to manage adverse events in the treatment of chronic constipation in Japan7
Short bowel syndrome-associated intestinal failure: diagnosis and prognosis7
A contemporary review of care gaps in hepatocellular carcinoma surveillance7
Before the scope: precision medicine in medication management for endoscopic safety and quality7
Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI)7
Mistakes in managing hepatocellular carcinoma and how to avoid them: a narrative review7
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn’s disease7
Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review7
Significance of nucleologenesis, ribogenesis, and nucleolar proteome in the pathogenesis and recurrence of hepatocellular carcinoma7
A critical review of upadacitinib for the treatment of adults with moderately to severely active ulcerative colitis7
Recent advances in the treatment of gastrointestinal motility disorders in children7
Adenoma detection rate in colonoscopy: how can it be improved?7
Letter to the editor: vitamin B12 deficiency and use of proton pump inhibitors: a systematic review and meta-analysis6
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease6
Securing the diagnosis of HRS-AKI: implications for current therapies6
Comprehensive care of ulcerative colitis: new treatment strategies6
Transjugular intrahepatic portosystemic shunt with or without variceal embolization to prevent variceal rebleeding: an updated meta-analysis6
Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study6
What are the true benefits of robotic pancreaticoduodenectomy for patients with pancreatic cancer?6
Advancements in the prevention and management of postoperative Crohn’s disease recurrence6
Endoscopic ultrasonography guided gallbladder drainage: “how and when”6
Etiologic factors for Barrett’s esophagus: toward countermeasures in Asia6
Statins decrease overall mortality and cancer related mortality but are underutilized in NAFLD: a longitudinal analysis of 12,538 individuals6
Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA Adverse Event Reporting System (FAERS) database6
Strengths and limitations of risk stratification tools for patients with upper gastrointestinal bleeding: a narrative review6
Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities6
Evaluating the molecular and genetic mechanisms underlying gut motility disorders6
Stratification of obesity phenotypes to optimize future therapy (SOPHIA)6
The emerging roles of intestinal organoid models in inflammatory bowel disease research6
Low-grade hepatocellular carcinoma characteristics, a practical nomogram and risk stratification system: a SEER population-based study6
Clinical efficacy and safety of robot assisted surgery for choledochal cysts excisions: a systematic review and meta-analysis5
Filgotinib for moderately to severely active ulcerative colitis5
Screening for pancreatic cancer has the potential to save lives, but is it practical?5
Sleeve gastrectomy with transit bipartition: a review of the literature5
Screening for MASLD in patients with type 2 diabetes: is an early diagnosis a good diagnosis?5
Spontaneous swallowing frequency in the evaluation of swallowing function5
How to predict abnormal acid reflux: recent developments5
Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making5
Cold resection for colorectal polyps: where we are and where we are going?5
Hepatobiliary disease after bone marrow transplant5
Occult hepatitis B infection – unveiling clinical burden and new diagnostic strategies5
From liver to gut: the hidden gastrointestinal impact of pediatric metabolic dysfunction-associated steatotic liver disease5
Update on biliary endoscopy: a comprehensive review5
Antireflux surgery – choosing the right candidate5
Irritable bowel syndrome in the elderly: epidemiology, diagnosis, treatment, and relationship with frailty5
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury5
Capsule endoscopy - a non-invasive modality to investigate the GI tract: out with the old and in with the new?5
Dual energy computed tomography in Crohn’s disease: a targeted review5
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis5
Is high resolution manometry pertinent in eosinophilic esophagitis assessment?5
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus5
Positioning of tofacitinib in treatment of ulcerative colitis: a global perspective5
EUS-guided tissue acquisition: past achievements, current challenges and future directions4
Abdominal pain in children: guidelines at last4
Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease4
Endoscopic ultrasound guided liver biopsy and portal pressure gradient: when, why and how? Can it become the standard of care in endo-hepatology?4
Diagnosis of peritoneal tuberculosis by real-time immuno-PCR assay based on detection of a cocktail ofMycobacterium tuberculosisCFP-10 and HspX proteins4
Identifying and managing rare subtypes of gastrointestinal stromal tumors4
Novel approaches in the medical management of compensated cirrhosis4
Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome4
Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease4
Antibiotics in decompensated liver disease – who, when and for how long?4
Validated approaches at mayo clinic for measuring gastric and colonic transit of solids and gastric accommodation4
Eosinophilic esophagitis in the era of biologics4
The value of endoscopic ultrasonography for differential diagnosis in obstructive jaundice of the distal common bile duct4
The non-surgical therapy of uncomplicated gallbladder stones: is there a niche?4
Electrosurgical unit in GI endoscopy: the proper settings for practice4
An overview of the efficacy, safety, and predictors of achalasia treatments4
Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages4
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics4
Advances in target drugs and immunotherapy for biliary tract cancer4
Antireflux surgeries and hiatal repair: keys to success4
Mistakes in utilising histopathology for the management of liver disease4
The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease4
Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms4
Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?4
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry4
Ulcerative colitis, frailty, and beyond4
Diagnosing and managing gastroparesis - where are we now?4
Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study3
Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives3
A critical review of adalimumab for the treatment of moderate-to-severe active ulcerative colitis in children3
A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments3
Response to letter: ‘Bayesian analysis and the role of local palliative therapeutics for malignant biliary obstruction’3
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the 3
Imaging in MASLD3
The clinical implications of trial endpoints in immunotherapy for hepatocellular carcinoma3
Pathophysiology and therapeutic management of anemia in gastrointestinal disorders3
The necessity and safety of simultaneous cholecystectomy during gastric surgery for patients with asymptomatic cholelithiasis3
Gastrointestinal reported outcomes following one anastomosis gastric bypass based on a multicenter study3
Could modulating the esophageal microbiome be the answer for eosinophilic esophagitis treatment?3
A critical review of technical progress, clinical heterogeneity, and implementation challenges of artificial intelligence in digestive endoscopy3
Risk factors associated with failure of endoscopic combined treatment to prevent varices rebleeding in patients with liver cirrhosis3
Cirrhosis and non-hepatic surgery in 2023 – a precision medicine approach3
Achalasia, from diagnosis to treatment3
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients3
New progress with calcium-binding protein S100A16 in digestive system disease3
Adjuvant therapy in biliary tract tumours: how will immunotherapy fit in the future?3
Same versus separate sessions of endoscopic ultrasound-guided fine-needle biopsy and endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction: a propensity score-matched3
Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review3
Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis3
Metabolic dysfunction-associated steatotic liver disease and gastrointestinal cancer risk in youth: is it time to unveil a hidden link?3
Gastric acid secretion therapy: long-term effects on gastric mucosa and polyp formation3
The role of videocapsule endoscopy in the diagnosis and follow-up of celiac disease: a scoping review3
Training in diagnostic and interventional endoscopic ultrasound: a state-of-the-art review3
Survival benefit of adjuvant transcatheter arterial chemoembolization for patients with hepatocellular carcinoma after anatomical hepatectomy3
Therapeutics for Clostridioides difficile infection: molecules and microbes3
Serological testing for celiac disease in children3
Hemostatic powders and gels in gastrointestinal endoscopy: current perspective and future recommendations3
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis3
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?3
Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials3
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review3
Research progress on short-term prognosis of acute-on-chronic liver failure3
Multiparametric intestinal ultrasound in inflammatory bowel diseases: a narrative review3
0.088818073272705